Literature DB >> 33368193

Smith-Magenis syndrome: Clinical and behavioral characteristics in a large retrospective cohort.

Nicolas Rive Le Gouard1, Adeline Jacquinet1,2, Lyse Ruaud1, Hélène Deleersnyder1, Faustine Ageorges1, Jennifer Gallard1, Didier Lacombe3, Sylvie Odent4, Myriam Mikaty4, Sylvie Manouvrier-Hanu5, Jamal Ghoumid5, David Geneviève6, Natacha Lehman6, Nicole Philip7, Patrick Edery8, Delphine Héron9, Coralie Rastel9, Sophie Chancenotte10, Christel Thauvin-Robinet10, Laurence Faivre10, Laurence Perrin1, Alain Verloes1.   

Abstract

Smith-Magenis syndrome (SMS), characterized by dysmorphic features, neurodevelopmental disorder, and sleep disturbance, is due to an interstitial deletion of chromosome 17p11.2 (90%) or to point mutations in the RAI1 gene. In this retrospective cohort, we studied the clinical, cognitive, and behavioral profile of 47 European patients with SMS caused by a 17p11.2 deletion. We update the clinical and neurobehavioral profile of SMS. Intrauterine growth was normal in most patients. Prenatal anomalies were reported in 15%. 60% of our patients older than 10 years were overweight. Prevalence of heart defects (6.5% tetralogy of Fallot, 6.5% pulmonary stenosis), ophthalmological problems (89%), scoliosis (43%), or deafness (32%) were consistent with previous reports. Epilepsy was uncommon (2%). We identified a high prevalence of obstipation (45%). All patients had learning difficulties and developmental delay, but ID range was wide and 10% of patients had IQ in the normal range. Behavioral problems included temper tantrums and other difficult behaviors (84%) and night-time awakenings (86%). Optimal care of SMS children is multidisciplinary and requires important parental involvement. In our series, half of patients were able to follow adapted schooling, but 70% of parents had to adapt their working time, illustrating the medical, social, educative, and familial impact of having a child with SMS.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  17p11.2; Smith-Magenis; clinical characteristics; neurodevelopmental disorder; obstipation; social impact

Mesh:

Year:  2021        PMID: 33368193     DOI: 10.1111/cge.13906

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  3 in total

1.  Prenatal Diagnosis of 17p11.2 Copy Number Abnormalities Associated With Smith-Magenis and Potocki-Lupski Syndromes in Fetuses.

Authors:  Meiying Cai; Xianguo Fu; Liangpu Xu; Na Lin; Hailong Huang
Journal:  Front Genet       Date:  2021-12-21       Impact factor: 4.599

Review 2.  Smith-Magenis Syndrome-Clinical Review, Biological Background and Related Disorders.

Authors:  Berardo Rinaldi; Roberta Villa; Alessandra Sironi; Livia Garavelli; Palma Finelli; Maria Francesca Bedeschi
Journal:  Genes (Basel)       Date:  2022-02-11       Impact factor: 4.096

Review 3.  DNA Methylation Episignatures in Neurodevelopmental Disorders Associated with Large Structural Copy Number Variants: Clinical Implications.

Authors:  Kathleen Rooney; Bekim Sadikovic
Journal:  Int J Mol Sci       Date:  2022-07-16       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.